These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12361531)

  • 1. [Variability of the clinical expression of Ecstasy-induced hepatotoxicity].
    Núñez O; Bañares R; Barrio J; Menchén L; Diego Ad; Salinero E; Clemente G
    Gastroenterol Hepatol; 2002 Oct; 25(8):497-500. PubMed ID: 12361531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute liver failure following the use of ecstasy (MDMA)].
    Lange-Brock N; Berg T; Müller AR; Fliege H; Neuhaus P; Wiedenmann B; Klapp BF; Mönnikes H
    Z Gastroenterol; 2002 Aug; 40(8):581-6. PubMed ID: 12297982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ecstasy induced acute hepatic failure. Case reports.
    Atayan Y; Çağın YF; Erdoğan MA; Harputluoglu MM; Bilgic Y
    Acta Gastroenterol Belg; 2015; 78(1):53-5. PubMed ID: 26118578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecstasy ingestion and fulminant hepatic failure: liver transplantation to be considered as a last therapeutic option.
    Garbino J; Henry JA; Mentha G; Romand JA
    Vet Hum Toxicol; 2001 Apr; 43(2):99-102. PubMed ID: 11308131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute hepatitis due to ingestion of Ecstasy].
    Huarte Muniesa MP; Pueyo Royo AM
    Rev Esp Enferm Dig; 1995 Sep; 87(9):681-3. PubMed ID: 7577130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecstasy induced hepatitis mimicking viral hepatitis.
    Dykhuizen RS; Brunt PW; Atkinson P; Simpson JG; Smith CC
    Gut; 1995 Jun; 36(6):939-41. PubMed ID: 7615289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation for the treatment of fulminant hepatic failure induced by the ingestion of ecstasy.
    Brauer RB; Heidecke CD; Nathrath W; Beckurts KT; Vorwald P; Zilker TR; Schweigart U; Hölscher AH; Siewert JR
    Transpl Int; 1997; 10(3):229-33. PubMed ID: 9163865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ("ecstasy") usage.
    Khakoo SI; Coles CJ; Armstrong JS; Barry RE
    J Clin Gastroenterol; 1995 Apr; 20(3):244-7. PubMed ID: 7797836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute liver damage and ecstasy ingestion.
    Ellis AJ; Wendon JA; Portmann B; Williams R
    Gut; 1996 Mar; 38(3):454-8. PubMed ID: 8675102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,4-methylenedioxymethamphetamine (MDMA): an important cause of acute hepatitis.
    Brncić N; Kraus I; Visković I; Mijandrusić-Sincić B; Vlahović-Palcevski V
    Med Sci Monit; 2006 Nov; 12(11):CS107-9. PubMed ID: 17072276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: multidetector CT and pathology findings.
    Lawler LP; Abraham S; Fishman EK
    J Comput Assist Tomogr; 2001; 25(4):649-52. PubMed ID: 11473199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Ecstasy"-induced hepatitis in an active duty soldier.
    Hwang I; Daniels AM; Holtzmuller KC
    Mil Med; 2002 Feb; 167(2):155-6. PubMed ID: 11873540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatic and hematological complications following ecstasy usage].
    Shibolet O; Kalish Y; Gillis S; Ilan Y
    Harefuah; 2001 Oct; 140(10):911-4, 991. PubMed ID: 11681122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Painless jaundice after ecstasy and alcohol consumption].
    Kis L; Pfaffenberger M
    Praxis (Bern 1994); 2007 Jun; 96(25-26):1035-7. PubMed ID: 17639967
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ecstasy-induced toxic hepatitis].
    Aknine X
    Presse Med; 2004 Oct; 33(18 Suppl):18-20. PubMed ID: 15617171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ecstasy induced fatal hepatic failure.
    Colak Y; Tuncer I; Enc FY; Ozturk O; Kiziltas S; Ulasoglu C
    J Gastrointestin Liver Dis; 2011 Jun; 20(2):215-6. PubMed ID: 21725523
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple toxicity from 3,4-methylenedioxymethamphetamine ("ecstasy").
    Greene SL; Dargan PI; O'connor N; Jones AL; Kerins M
    Am J Emerg Med; 2003 Mar; 21(2):121-4. PubMed ID: 12671812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute liver failure caused by methylenedioxymethamphetamine ('ecstasy')].
    de Man RA; Wilson JH; Tjen HS
    Ned Tijdschr Geneeskd; 1993 Apr; 137(14):727-9. PubMed ID: 8097286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperkalemia in fatal MDMA ('ecstasy') toxicity.
    Raviña P; Quiroga JM; Raviña T
    Int J Cardiol; 2004 Feb; 93(2-3):307-8. PubMed ID: 14975567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ecstasy: a common cause of severe acute hepatotoxicity.
    Andreu V; Mas A; Bruguera M; Salmerón JM; Moreno V; Nogué S; Rodés J
    J Hepatol; 1998 Sep; 29(3):394-7. PubMed ID: 9764985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.